Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanPan: Sativex and Gentamicin in Older Patients
NCT05503147Phase 1Unknown
- Start
- Mar 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Malnutrition and anorexia nervosa (AN) comparing Sativex first with Placebo first (2 arms). Primary endpoints: Difference in energy intake and Differences in the objective function value of the population-based pharmacokinetic model. Status: unknown.
02
Drugs
cannabis extract
03
Conditions
Malnutritionanorexia nervosa (AN)
Beyond the preview
Go deeper on NCT05503147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05503147.